Vedere Bio II, Inc., a company developing next-generation therapies for vision restoration and preservation in patients with vision loss due to photoreceptor death, announced the appointment of Martina Schinke, Ph.D., as Vice President, Program Leader.
February 8, 2022
· 3 min read